Drug intelligence / Profile preview

Xiaoer Jinqiao granules

Development stage
Unknown
Lead developer
Yifan Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Xiaoer Jinqiao granules (also known as Xiaoer Qingiao granules) is a traditional Chinese patent medicine developed and manufactured by Sichuan Kaijing Pharmaceutical, a subsidiary of Yifan Pharmaceutical. It is formulated from seven traditional Chinese herbs: Lonicera japonica (honeysuckle), Forsythia suspensa, Pueraria lobata (kudzu root), Isatis tinctoria (isatis leaf), Sophora tonkinensis (tonkin sophora root), Bupleurum chinense (bupleurum root), and Glycyrrhiza uralensis (licorice). The granules are primarily indicated for the treatment of wind-heat syndrome in children, which manifests as fever, aversion to cold, sore throat, difficulty swallowing, and cough. It is widely used in China for pediatric acute tonsillitis and is being evaluated in Phase 4 clinical trials for pediatric influenza.

Brand names
Bi Bi GaoBibigaoYi Xin HeYixinhe一欣和比比高
Other names
Xiao'er Jinqiao GranulesXiao'er Qingiao GranulesXiaoer Jinqiao GranulesXiaoer Qingiao Granules小儿金翘颗粒小儿青翘颗粒

Beyond the preview

Go deeper on Xiaoer Jinqiao granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoer Jinqiao granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call